LENZ Therapeutics LENZ
NASDAQ LENZ
$3.58 -0.21 (-5.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

LENZ Therapeutics (LENZ) Sales of Property, Plant and Equipment (2023)

Updated

LENZ Therapeutics (LENZ) recorded Sales of Property, Plant and Equipment of $679,000 in Q4 2023, down 23.5% from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Sales of Property, Plant and Equipment (2023) Analysis & Trends

For FY2023, LENZ Therapeutics reported Sales of Property, Plant and Equipment of $1.9 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 LENZ Therapeutics 112.47 Mn 112.47 Mn 5.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 679,000.00
Sep 30, 2023 888,000.00
API Access

LENZ Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=LENZ&period=max&api_key=YOUR_API_KEY